Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-049149
Filing Date
2024-11-25
Accepted
2024-11-25 16:26:09
Documents
1
Period of Report
2024-11-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1732569962.html 4  
1 FORM 4 wk-form4_1732569962.xml 4 5443
  Complete submission text file 0001628280-24-049149.txt   6909
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Issuer) CIK: 0001723128 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PARDES BIOSCIENCES, INC. 2173 SALK AVE., SUITE 250, PMB#052 CARLSBAD CA 92008
Business Address
Autor Deborah M. (Reporting) CIK: 0001884671 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38485 | Film No.: 241496258